IMTX.NASDAQImmatics NV

SCHEDULE: RTW Investments Maintains 7.3% Stake in Immatics N.V.

Sentiment:

Beneficial Ownership Report (Amendment)


RTW Investments, LP and Roderick Wong, M.D. have filed an amendment to their Schedule 13G, reporting a continued 7.3% beneficial ownership in Immatics N.V. as of September 30, 2025.

Summary

  • RTW Investments, LP and its Managing Partner, Roderick Wong, M.D., collectively reported beneficial ownership of 8,815,617 Ordinary Shares of Immatics N.V.
  • This ownership represents 7.3% of Immatics N.V.'s outstanding Ordinary Shares.
  • The percentage is calculated based on 121,550,169 shares outstanding as of June 30, 2025, as reported in the Issuer's Form 6-K filed on August 13, 2025.
  • The shares are held by RTW Funds, for which RTW Investments acts as an investment adviser.
  • The filing is an Amendment No. 2 to a Schedule 13G, indicating an update to a previously reported significant stake.
  • The Reporting Persons certify that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 6

Explanation: The filing is a routine disclosure of a significant institutional ownership stake. The continued holding of a 7.3% stake by a specialized investment firm like RTW Investments can be viewed as a moderately positive signal of conviction in Immatics N.V.'s prospects, though the filing itself is purely factual.

Positives

  • A significant 7.3% stake held by a reputable investment firm like RTW Investments, LP, and its Chief Investment Officer, Roderick Wong, M.D., signals continued institutional confidence in Immatics N.V.

Future Outlook

NA

Management Comments

  • "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."

Industry Context

NA

Stakeholder Impact

  • Shareholders: The disclosure provides transparency regarding a significant institutional investor's stake, which can influence market perception and trading activity. A large, stable institutional holder may contribute to share price stability or signal confidence.

Key Dates

DateDescription
06/30/2025Date as of which 121,550,169 Ordinary Shares of Immatics N.V. were reported outstanding in a Form 6-K.
08/13/2025Date Immatics N.V. filed its Form 6-K reporting shares outstanding.
09/30/2025Date of event which requires the filing of this Schedule 13G statement (reporting period end date).
11/14/2025Date the Schedule 13G Amendment No. 2 was signed and filed by RTW Investments, LP and Roderick Wong, M.D.

Keywords

Immatics N.V., RTW Investments, Roderick Wong, Beneficial Ownership, Schedule 13G, Institutional Investor, Ordinary Shares, Biotechnology, Investment Adviser

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.